CN Patent

CN108524505A — 用于细胞增殖相关病症的方法和组合物

Assigned to Agios Pharmaceuticals Inc · Expires 2018-09-14 · 8y expired

What this patent protects

本发明涉及用于细胞增殖相关病症的方法和组合物。本文描述了治疗和评估具有新活性突变体的受试者的方法。

USPTO Abstract

本发明涉及用于细胞增殖相关病症的方法和组合物。本文描述了治疗和评估具有新活性突变体的受试者的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108524505A
Jurisdiction
CN
Classification
—
Expires
2018-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.